{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:27:25Z","timestamp":1778794045100,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10856-020-06438-x","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T18:03:21Z","timestamp":1602266601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Tryptophan conjugated magnetic nanoparticles for targeting tumors overexpressing indoleamine 2,3 dioxygenase (IDO) and L-type amino acid transporter"],"prefix":"10.1007","volume":"31","author":[{"given":"Rashi","family":"Mathur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram Prakash","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurjaspreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raunak","family":"Varshney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanyog","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"6438_CR1","doi-asserted-by":"crossref","unstructured":"Estelrich J, S\u00e1nchez-Mart\u00edn MJ, Busquets MA. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. Int J Nanomed. 2015;10:1727\u201341.","DOI":"10.2147\/IJN.S76501"},{"key":"6438_CR2","doi-asserted-by":"crossref","unstructured":"Stephen ZR, Kievit FM, Zhang M. Magnetite nanoparticles for medical MR imaging. Mater Today. Elsevier B.V.; 2011;14:330\u20138.","DOI":"10.1016\/S1369-7021(11)70163-8"},{"key":"6438_CR3","doi-asserted-by":"crossref","unstructured":"Bouchard LS, Anwar MS, Liu GL, Hann B, Xie ZH, Gray JW, et al. Picomolar sensitivity MRI and photoacoustic imaging of cobalt nanoparticles. Proc Natl Acad Sci USA. 2009;106:4085\u20139.","DOI":"10.1073\/pnas.0813019106"},{"key":"6438_CR4","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.addr.2008.03.018","volume":"60","author":"C Sun","year":"2008","unstructured":"Sun C, Lee JSH, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 2008;60:1252\u201365.","journal-title":"Adv Drug Deliv Rev"},{"key":"6438_CR5","doi-asserted-by":"crossref","unstructured":"Yoo J, Park C, Yi G, Lee D, Koo H. Active targeting strategies using biological ligands for nanoparticle drug delivery systems. Cancers. 2019;11:640.","DOI":"10.3390\/cancers11050640"},{"key":"6438_CR6","doi-asserted-by":"publisher","unstructured":"Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9. https:\/\/doi.org\/10.1038\/s41467-018-03705-y.","DOI":"10.1038\/s41467-018-03705-y"},{"key":"6438_CR7","doi-asserted-by":"crossref","unstructured":"Friedman A, Claypool S, Liu R. The smart targeting of nanoparticles. Curr Pharm Des. 2013;19:6315\u201329.","DOI":"10.2174\/13816128113199990375"},{"key":"6438_CR8","doi-asserted-by":"crossref","unstructured":"Hayashi K, Anzai N. Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment. World J. Gastrointest. Oncol. 2017;9:21\u20139.","DOI":"10.4251\/wjgo.v9.i1.21"},{"key":"6438_CR9","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.drudis.2016.12.003","volume":"22","author":"MJ Lukey","year":"2017","unstructured":"Lukey MJ, Katt WP, Cerione RA. Targeting amino acid metabolism for cancer therapy. Drug Discov Today. 2017;22:796\u2013804.","journal-title":"Drug Discov Today"},{"key":"6438_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tem.2013.01.002","volume":"24","author":"AN McCracken","year":"2013","unstructured":"McCracken AN, Edinger AL. Nutrient transporters: The Achilles\u2019 heel of anabolism. Trends Endocrinol Metab. 2013;24:200\u20138.","journal-title":"Trends Endocrinol Metab"},{"key":"6438_CR11","doi-asserted-by":"crossref","unstructured":"Li J, Guo Y, Kuang Y, An S, Ma H, Jiang C. Choline transporter-targeting and co-delivery system for glioma therapy. Biomaterials. 2013;34:9142\u20138.","DOI":"10.1016\/j.biomaterials.2013.08.030"},{"key":"6438_CR12","doi-asserted-by":"crossref","unstructured":"Su H, Wang Y, Liu S, Wang Y, Liu Q, Liu G, et al. Emerging transporter-targeted nanoparticulate drug delivery systems. Acta Pharm. Sin. B. 2019;9:49\u201358.","DOI":"10.1016\/j.apsb.2018.10.005"},{"key":"6438_CR13","doi-asserted-by":"crossref","unstructured":"Jiang X, Xin H, Ren Q, Gu J, Zhu L, Du F, et al. Nanoparticles of 2-deoxy-d-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. Biomaterials. 2014;35:518\u201329.","DOI":"10.1016\/j.biomaterials.2013.09.094"},{"key":"6438_CR14","unstructured":"De Boer ABG, De Lange ELCM, Van Der Sandt ICJ, Breimer DD. Transporters and the blood-brain barrier (BBB). Int J Clin Pharmacol Ther. 1998;15:1657\u201365."},{"key":"6438_CR15","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1021\/nn300240p","volume":"6","author":"R Qiao","year":"2012","unstructured":"Qiao R, Jia Q, H\u00fcwel S, Xia R, Liu T, Gao F, et al. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. ACS Nano. 2012;6:3304\u201310.","journal-title":"ACS Nano"},{"key":"6438_CR16","doi-asserted-by":"crossref","unstructured":"Pulgar VM. Transcytosis to cross the blood brain barrier, new advancements and challenges. Front Neurosci. 2019;1019.","DOI":"10.3389\/fnins.2018.01019"},{"key":"6438_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5582\/irdr.2015.01024","volume":"4","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Wang L, Pan J. The role of L-type amino acid transporter 1 in human tumors. Intractable Rare Dis Res. 2015;4:165\u20139.","journal-title":"Intractable Rare Dis Res"},{"key":"6438_CR18","doi-asserted-by":"crossref","unstructured":"Fotiadis D, Kanai Y, Palac\u00edn M. The SLC3 and SLC7 families of amino acid transporters. Mol. Aspects Med. 2013;1845\u201354.","DOI":"10.1016\/j.mam.2012.10.007"},{"key":"6438_CR19","doi-asserted-by":"crossref","unstructured":"Hiraoka N, Toue S, Okamoto C, Kikuchi S, Ino Y, Yamazaki-Itoh R, et al. Tissue amino acid profiles are characteristic of tumor type, malignant phenotype, and tumor progression in pancreatic tumors. Sci Rep. 2019;9816.","DOI":"10.1038\/s41598-019-46404-4"},{"key":"6438_CR20","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.7150\/jca.31727","volume":"10","author":"Z Ye","year":"2019","unstructured":"Ye Z, Yue L, Shi J, Shao M, Wu T. Role of IDO and TDO in cancers and related diseases and the therapeutic implications. J Cancer. 2019;10:2771\u201382.","journal-title":"J Cancer"},{"key":"6438_CR21","doi-asserted-by":"crossref","unstructured":"Liu M, Wang X, Wang L, Ma X, Gong Z, Zhang S, et al. Targeting the IDO1 pathway in cancer: from bench to bedside. J. Hematol. Oncol. 2018;11:100.","DOI":"10.1186\/s13045-018-0644-y"},{"key":"6438_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12645-011-0021-9","volume":"2","author":"RP Chauhan","year":"2011","unstructured":"Chauhan RP, Singh G, Singh S, Bag N, Patra M, Vadera SR, et al. Biotinylated magnetic nanoparticles for pretargeting: synthesis and characterization study. Cancer Nanotechnol. 2011;2:111\u201320.","journal-title":"Cancer Nanotechnol"},{"key":"6438_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1166\/jbn.2013.1548","volume":"9","author":"RP Chauhan","year":"2013","unstructured":"Chauhan RP, Mathur R, Singh G, Kaul A, Bag N, Singh S, et al. Evaluation of folate conjugated superparamagnetic iron oxide nanoparticles for scintigraphic\/magnetic resonance imaging. J Biomed Nanotechnol. 2013;9:323\u201334.","journal-title":"J Biomed Nanotechnol"},{"key":"6438_CR24","doi-asserted-by":"crossref","unstructured":"Keepers YP, Pizao PE, Peters GJ, van Ark-Otte J, Winograd B, Pinedo HM. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer Clin Oncol. 1991;27:897\u2013900.","DOI":"10.1016\/0277-5379(91)90142-Z"},{"key":"6438_CR25","doi-asserted-by":"crossref","unstructured":"Skehan P, Storeng R, Scudiero D, Monks A, Mcmahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82;107\u201312.","DOI":"10.1093\/jnci\/82.13.1107"},{"key":"6438_CR26","doi-asserted-by":"publisher","first-page":"12798","DOI":"10.1021\/ja016812s","volume":"123","author":"T Hyeon","year":"2001","unstructured":"Hyeon T, Su Seong Lee, Park J, Chung Y, Hyon Bin Na, Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc. 2001;123:12798\u2013801.","journal-title":"J Am Chem Soc"},{"key":"6438_CR27","doi-asserted-by":"crossref","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:57.","DOI":"10.3390\/pharmaceutics10020057"},{"key":"6438_CR28","doi-asserted-by":"crossref","unstructured":"\u00c7ak\u0131r S, Bi\u00e7er E. Synthesis, spectroscopic and electrochemical characteristics of a novel Schiff-base from saccharin and tryptophan. J Iran Chem Soc. 2010;7:394\u2013404.","DOI":"10.1007\/BF03246025"},{"key":"6438_CR29","doi-asserted-by":"crossref","unstructured":"Ma L, Li Y, Li L, Wu Y, Buchet R, Ding Y. Clarification of the binding model of lead(II) with a highly sensitive and selective fluoroionophore sensor by spectroscopic and structural study. Spectrochim Acta - Part A Mol Biomol Spectrosc. 2009;72:306\u201311.","DOI":"10.1016\/j.saa.2008.09.014"},{"key":"6438_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0304-8853(97)01057-3","volume":"183","author":"M Zheng","year":"1998","unstructured":"Zheng M, Wu XC, Zou BS, Wang YJ. Magnetic properties of nanosized MnFe2O4 particles. J Magn Magn Mater. 1998;183:152\u20136.","journal-title":"J Magn Magn Mater"},{"key":"6438_CR31","doi-asserted-by":"crossref","unstructured":"Sun S, Zeng H, Robinson DB, Raoux S, Rice PM, Wang SX, et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) Nanoparticles. J Am Chem Soc. 2004;126:273\u20139.","DOI":"10.1021\/ja0380852"},{"key":"6438_CR32","doi-asserted-by":"crossref","unstructured":"Gillis P, Koenig SH. Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite. Magn Reson Med. 1987;5:323\u201345.","DOI":"10.1002\/mrm.1910050404"},{"key":"6438_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/mrm.10064","volume":"47","author":"RA Brooks","year":"2002","unstructured":"Brooks RA, Moiny F, Gillis P. On T2-shortening by strongly magnetized spheres: a partial refocusing model. Magn Reson Med. 2002;47:257\u201363.","journal-title":"Magn Reson Med"},{"key":"6438_CR34","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/mrm.1135","volume":"45","author":"RA Brooks","year":"2001","unstructured":"Brooks RA, Moiny F, Gillis P. On T2-shortening by weakly magnetized particles: the chemical exchange model. Magn Reson Med. 2001;45:1014\u201320.","journal-title":"Magn Reson Med"},{"key":"6438_CR35","doi-asserted-by":"crossref","unstructured":"Thapa B, Diaz-Diestra D, Beltran-Huarac J, Weiner BR, Morell G. Enhanced MRI T 2 relaxivity in contrast-probed anchor-free PEGylated iron oxide nanoparticles. Nanoscale Res Lett. 2017;312.","DOI":"10.1186\/s11671-017-2084-y"},{"key":"6438_CR36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jmmm.2004.01.094","volume":"279","author":"M Yamaura","year":"2004","unstructured":"Yamaura M, Camilo RL, Sampaio LC, Mac\u00eado MA, Nakamura M, Toma HE. Preparation and characterization of (3-aminopropyl)triethoxysilane-coated magnetite nanoparticles. J Magn Magn Mater. 2004;279:210\u20137.","journal-title":"J Magn Magn Mater"},{"key":"6438_CR37","doi-asserted-by":"crossref","unstructured":"Knappett BR, Abdulkin P, Ringe E, Jefferson DA, Lozano-Perez S, Rojas TC, et al. Characterisation of Co@Fe3O4 core@shell nanoparticles using advanced electron microscopy. Nanoscale. 2013;5765\u201329.","DOI":"10.1039\/c3nr33789h"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-020-06438-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10856-020-06438-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-020-06438-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T06:55:21Z","timestamp":1633848921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10856-020-06438-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["6438"],"URL":"https:\/\/doi.org\/10.1007\/s10856-020-06438-x","relation":{},"ISSN":["0957-4530","1573-4838"],"issn-type":[{"value":"0957-4530","type":"print"},{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"19 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"87"}}